Total Payments
$228,853
2024 Payments
$4,102
Companies
50
Transactions
1,375
Medicare Patients
8,972
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$200,781 (87.7%)
Food & Beverage$25,126 (11.0%)
Travel$2,289 (1.0%)
Education$356.55 (0.2%)
Consulting$300.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200,781 | 105 | 87.7% |
| Food and Beverage | $25,126 | 1,248 | 11.0% |
| Travel and Lodging | $2,289 | 5 | 1.0% |
| Education | $356.55 | 16 | 0.2% |
| Consulting Fee | $300.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $97,178 | 241 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $45,939 | 114 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $23,407 | 230 | $0 (2024) |
| Amarin Pharma Inc. | $23,086 | 59 | $0 (2023) |
| Kowa Pharmaceuticals America, Inc. | $12,282 | 51 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $8,167 | 33 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $5,644 | 36 | $0 (2023) |
| Esperion Therapeutics, Inc. | $2,154 | 4 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,844 | 109 | $0 (2024) |
| Boston Scientific Corporation | $1,043 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,102 | 140 | Janssen Pharmaceuticals, Inc ($1,151) |
| 2023 | $3,961 | 131 | Janssen Pharmaceuticals, Inc ($1,397) |
| 2022 | $21,497 | 166 | Janssen Pharmaceuticals, Inc ($19,467) |
| 2021 | $27,189 | 131 | Janssen Pharmaceuticals, Inc ($17,452) |
| 2020 | $36,625 | 86 | AstraZeneca Pharmaceuticals LP ($25,796) |
| 2019 | $35,732 | 199 | Janssen Pharmaceuticals, Inc ($20,739) |
| 2018 | $16,171 | 176 | Janssen Pharmaceuticals, Inc ($8,607) |
| 2017 | $83,574 | 346 | Janssen Pharmaceuticals, Inc ($20,179) |
All Payment Transactions
1,375 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | AGEPHA Pharma FZ LLC | LODOCO (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Cardiovascular Diseases | ||||||
| 12/24/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $44.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/19/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Cardiology | ||||||
| 12/10/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $128.13 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 12/10/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $73.22 | General |
| Category: Cardiology | ||||||
| 12/10/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $73.21 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.96 | General |
| Category: Cardiovascular | ||||||
| 12/09/2024 | Silk Road Medical, Inc. | ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter (Device), ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Neuroprotection System | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardiology | ||||||
| 12/03/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Obesity | ||||||
| 11/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | Boston Scientific Corporation | Guidezilla (Device) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Guidezilla_IC | ||||||
| 11/14/2024 | Boston Scientific Corporation | Comet (Device) | Food and Beverage | In-kind items and services | $8.12 | General |
| Category: Comet_IC | ||||||
| 11/13/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $37.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Cardiology | ||||||
| 11/01/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Cardiology | ||||||
| 10/31/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Cardiology | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.11 | General |
| 10/29/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 3,143 | 4,820 | $3.0M | $365,305 |
| 2022 | 22 | 2,004 | 3,249 | $2.1M | $255,291 |
| 2021 | 20 | 2,109 | 3,270 | $1.6M | $278,164 |
| 2020 | 17 | 1,716 | 2,542 | $717,836 | $213,278 |
Total Patients
8,972
Total Services
13,881
Medicare Billing
$1.1M
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 529 | 1,371 | $1.1M | $132,389 | 11.6% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 61 | 61 | $39,251 | $29,782 | 75.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 174 | 189 | $253,694 | $29,469 | 11.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 78 | 78 | $239,472 | $29,135 | 12.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 198 | 369 | $176,431 | $23,876 | 13.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 142 | 148 | $183,453 | $21,028 | 11.5% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 25 | 32 | $117,151 | $14,183 | 12.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 215 | 221 | $94,356 | $11,894 | 12.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 53 | 55 | $100,365 | $10,359 | 10.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 40 | 95 | $88,889 | $9,388 | 10.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 51 | 204 | $100,012 | $8,486 | 8.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 72 | 72 | $78,026 | $8,236 | 10.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 461 | 674 | $66,350 | $7,508 | 11.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 560 | 715 | $41,212 | $4,678 | 11.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 86 | 86 | $40,868 | $4,072 | 10.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 25 | $29,627 | $3,791 | 12.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $21,912 | $2,788 | 12.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $20,484 | $2,541 | 12.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 33 | 33 | $16,179 | $1,910 | 11.8% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 52 | 56 | $14,461 | $1,830 | 12.7% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 26 | 41 | $15,168 | $1,708 | 11.3% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 16 | 17 | $11,044 | $1,404 | 12.7% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 26 | 38 | $10,359 | $1,336 | 12.9% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Office | 2023 | 15 | 16 | $7,992 | $924.10 | 11.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 70 | 78 | $26,774 | $788.12 | 2.9% |
About Dr. Scott Eisenberg, DO
Dr. Scott Eisenberg, DO is a Cardiovascular Disease healthcare provider based in Eatontown, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1891778353.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Eisenberg, DO has received a total of $228,853 in payments from pharmaceutical and medical device companies, with $4,102 received in 2024. These payments were reported across 1,375 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($200,781).
As a Medicare-enrolled provider, Eisenberg has provided services to 8,972 Medicare beneficiaries, totaling 13,881 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Eatontown, NJ
- Active Since 11/29/2005
- Last Updated 05/20/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891778353
Products in Payments
- XARELTO (Drug) $97,178
- FARXIGA (Drug) $44,965
- Vascepa (Drug) $23,086
- ENTRESTO (Drug) $22,568
- Livalo (Drug) $12,266
- PRALUENT ALIROCUMAB INJECTION (Biological) $8,017
- PRALUENT (Drug) $5,339
- NEXLIZET (Drug) $2,125
- UPTRAVI (Drug) $1,365
- LEQVIO (Drug) $839.00
- BRILINTA (Drug) $827.13
- ELIQUIS (Drug) $774.77
- Repatha (Biological) $739.84
- ORENITRAM (Drug) $464.38
- JARDIANCE (Drug) $399.00
- ZIO XT Patch (Device) $384.74
- Adempas (Drug) $381.30
- VERQUVO (Drug) $357.00
- LifeVest (Device) $330.89
- OPSUMIT (Drug) $307.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Eatontown
Dr. Brett Sealove, M.d, M.D
Cardiovascular Disease — Payments: $505,646
Cardiovascular Disease $505,646
Dr. Mark Mascarenhas, Md, MD
Cardiovascular Disease — Payments: $43,031
Cardiovascular Disease $43,031
Dr. Eran Zacks, Md, MD
Cardiovascular Disease — Payments: $36,057
Cardiovascular Disease $36,057
Dr. Nelson Lamarche, M.d, M.D
Cardiovascular Disease — Payments: $16,389
Cardiovascular Disease $16,389
Dr. Ajay Shah, Md, Ms, Frcs, Dnb, MD, MS, FRCS, DNB
Cardiovascular Disease — Payments: $9,713
Cardiovascular Disease $9,713
Dr. Lynne Einbinder, M.d, M.D
Cardiovascular Disease — Payments: $9,203
Cardiovascular Disease $9,203